[The criteria of disorders in body antitumor resistance in subjects with dyshemopoiesis]. / Kriterii narushenii protivoopukholevoi rezistentnosti organizma u lits s disgemopoézom.

A complex of methods is proposed adapted to practices common in clinical and diagnostic laboratories that enables the state of bodily antitumoral resistance to be properly assessed. A diagnostic system of disturbances in the antineoplastic resistance of the organism, which makes for detection of endogenous factors marking a high risk for the development of oncohemopathology is suggested.

[The efficacy of active specific immunotherapy using modified neoplastic cells in the combined modality treatment of hemoblastoses]. / Effektivnost' aktivnoi spetsificheskoi immunoterapii modifitsirovannymi neoplasticheskimi kletkami v kompleksnom lechenii gemoblastozov.

Efficiency was studied of active specific immunotherapy (IT) with cell vaccine consisting of allogenic viable cryopreserved modified Con A blast cells identical with the illness in patients with acute myeloblastic leukemia and acute lymphoblastic leukemia. The studies made confirmed a positive impact of IT on the clinical course of acute leukosis (prolonged remission, keeping down infectious complications), on leukopoiesis, peripheral blood cells enzymatic status as well as on cell immunity, certain factors of humoral immunity and bodily natural antineoplastic resistance.